Demand for resveratrol in Korea is anticipated to exhibit a CAGR of 9.4% through 2033. Sales of resveratrol in Korea are expected to grow considerably, from USD 2.25 million in 2023 to around USD 5.52 million by 2033.
Key Insights for the Resveratrol Industry in Korea
| Attributes | Key Statistics |
|---|---|
| Expected Base Year Value (2023) | USD 2.25 million |
| Anticipated Forecast Value (2033) | USD 5.52 million |
| Estimated Growth (2023 to 2033) | 9.4% CAGR |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
In the last few years, there has been a considerable push toward natural and clean-labeled products not just in Korea but all over the world. Natural resveratrol is commonly found in certain foods, such as red grapes, berries, and peanuts, making it a perfect choice for consumers actively seeking nutrients and bioactive compounds directly from natural sources.
On the basis of product type, natural resveratrol dominates the Korean industry with a whopping share of 82.6%. The demand for natural resveratrol is also attributed to a broader cultural shift towards sustainability and environmental consciousness. The Korean population is becoming increasingly aware of the environmental consequences of synthetic resveratrol production, making natural resveratrol an ideal choice.
| Attributes | Details |
|---|---|
| Product Type | Natural |
| Value Share in 2023 | 82.60% |
The Korean population is rapidly embracing resveratrol as a dietary supplement. As a stable and concentrated form of resveratrol, solid supplements offer convenience and ease of integration into daily routines. Unlike liquid or raw dietary sources, solid resveratrol allows for precise dosage control, ensuring individuals can easily incorporate the recommended amount into their dietary regimens.
On the basis of form, solid resveratrol dominates the Korean industry, with a remarkable share of 84.90%. The demand for solid resveratrol is also skyrocketing as it addresses concerns related to bioavailability, a common challenge associated with the compound. This improved bioavailability ensures that individuals can harness the full potential of resveratrol's health benefits.
| Attributes | Details |
|---|---|
| Form | Solid |
| Value Share in 2023 | 84.90% |
Post-pandemic, there has been an exponential rise in the Korean nutraceuticals and cosmeceutical industry, ultimately positively impacting the resveratrol industry. It is observed that there has been a substantial influx of foreign companies into the country. Industry giants from Korea already have a strong foothold, making it challenging for small companies to sustain themselves. Despite this, they continue to come up with new innovations in the industry.
Recent Developments in the Resveratrol Industry in Korea
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
| Attribute | Details |
|---|---|
| Estimated Valuation (2023) | USD 2.25 million |
| Projected Valuation (2033) | USD 5.52 million |
| Anticipated CAGR (2023 to 2033) | 9.4% CAGR |
| Historical Analysis of the Resveratrol in Korea | 2018 to 2022 |
| Demand Forecast for Resveratrol in Korea | 2023 to 2033 |
| Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Key Companies Profiled | Dong-A Pharmaceutical Co., Ltd.; CJ CheilJedang Corporation; Wellvita Co., Ltd.; Cosmax Co., Ltd.; Celltrion Inc.; Kolon Life Sciences Co., Ltd.; Green Cross Pharma Co., Ltd.; LG Chem Life Sciences Co., Ltd.; Samsung Fine Chemicals Co., Ltd.; Hanmi Pharmaceutical Co., Ltd. |
The anticipated CAGR for the Korea resveratrol industry through 2033 is 9.4%.
The resveratrol industry in Korea is likely to reach USD 5.52 million by 2033.
Solid resveratrol is the most preferred form of resveratrol in Korea, with an industry share of 84.90%.
In Korea, natural resveratrol dominates the industry, with a share of 82.60%.
Dong-A Pharmaceutical Co., Ltd., CJ CheilJedang Corporation, Wellvita Co., Ltd., Cosmax Co., Ltd, are some of the leading players in this industry.
| Estimated Market Size (2024E) | USD 129 million |
|---|---|
| Projected Market Value (2034F) | USD 356.4 million |
| Value-based CAGR (2024 to 2034) | 10.7% |
| Expected Market Value (2023) | USD 177.96 million |
|---|---|
| Projected Forecast Value (2033) | USD 391.37 million |
| Anticipated CAGR (2023 to 2033) | 8% |
| Market Valuation (2023) | USD 43 million |
|---|---|
| Market Valuation (2033) | USD 73.7 million |
| Market CAGR (2023 to 2033) | 6% |
Explore Functional Food Ingredients Insights
View Reports
Resveratrol Industry Analysis in Korea
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
